October 2, 2026
Reviewed by Anil Kumar Goel, B.Pharm — Chairman, Biozia Lifesciences, 40+ years in the pharmaceutical industry.
Etoricoxib is one of the most-prescribed pain and arthritis molecules in Indian orthopaedic and general practice, and the 60, 90 and 120 mg strengths are each tied to specific indications. This guide explains what etoricoxib does, how each strength is used, the safety points pharmacists and distributors should know, and how Biozia supplies it as the Ziacox-60, Ziacox-90 and Ziacox-120 range for PCD franchise and third-party manufacturing.
Etoricoxib is available as film-coated tablets in three strengths. Biozia manufactures all three:
| Brand | Composition | Packing |
|---|---|---|
| Ziacox-60 Tablet | Etoricoxib 60 mg | 10×10 Blister |
| Ziacox-90 Tablet | Etoricoxib 90 mg | 10×10 Alu/Alu |
| Ziacox-120 Tablet | Etoricoxib 120 mg | 10×10 Alu/Alu |
Pain and inflammation are driven largely by prostaglandins made by the cyclo-oxygenase-2 (COX-2) enzyme. Etoricoxib selectively blocks COX-2 while largely sparing COX-1, the enzyme that protects the stomach lining and supports platelet function. The result is anti-inflammatory and analgesic action similar to traditional NSAIDs, with a lower rate of gastric irritation and ulcers. Its long half-life (about 22 hours) allows once-daily dosing.
Doses below reflect the commonly approved adult indications. The prescribing doctor decides the actual dose and duration.
Etoricoxib can be taken with or without food; it works faster on an empty stomach. Doses above the indicated maximum do not add benefit and increase risk.
Common side effects include indigestion, abdominal discomfort, swelling of the feet (fluid retention), raised blood pressure, dizziness and headache. Less commonly it can cause gastrointestinal bleeding, kidney problems, liver enzyme elevation or allergic reactions. Like all NSAIDs it may increase the risk of heart attack and stroke, especially at higher doses and with longer use.
Etoricoxib is a steady, repeat-prescription molecule in orthopaedic, rheumatology and general practice, which makes it a reliable anchor product for a pain-management range. Biozia manufactures Ziacox-60 (10×10 blister) and Ziacox-90 and Ziacox-120 (10×10 Alu/Alu), alongside the etoricoxib combinations Ziacox-P and Ziacox-T4.
Interested in etoricoxib tablets for your territory or your own brand? Enquire with Biozia Lifesciences →
The strength depends on the condition. 60 mg is used for osteoarthritis, 90 mg for rheumatoid arthritis, ankylosing spondylitis and short-term acute pain, and 120 mg only for acute gout attacks for up to 8 days.
Etoricoxib is COX-2 selective, so it generally causes fewer stomach ulcers than non-selective NSAIDs such as diclofenac. It still carries cardiovascular and blood-pressure risks and is not suitable for everyone.
It is taken once daily, but long-term use should be decided and reviewed by a doctor, using the lowest effective dose.
Yes. Ziacox-60, Ziacox-90 and Ziacox-120 are available for PCD franchise with monopoly rights, and etoricoxib tablets can also be made under your own brand through third-party manufacturing.
This guide is for pharmacists, doctors, distributors and trade partners. It is general product information, not medical advice — patients should take any medicine only as prescribed by a registered medical practitioner.
Get monopoly rights, a wide product range and full marketing support in your territory.